Monte Carlo dosimetry of a novel Yttrium-90 disc source for episcleral brachytherapy.


Journal

Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176

Informations de publication

Date de publication:
Dec 2023
Historique:
revised: 10 08 2023
received: 24 02 2023
accepted: 11 08 2023
medline: 4 12 2023
pubmed: 14 9 2023
entrez: 14 9 2023
Statut: ppublish

Résumé

To calculate the dose distribution using Monte Carlo simulations for a novel high-dose-rate Yttrium-90 (Y-90) disc source recently developed for episcleral brachytherapy and provide a lookup table for treatment planning. Monte Carlo simulations were performed to calculate the in-water dose distribution of the Y-90 disc source using the "GATE", a software based on the "Geant4" Monte Carlo simulation toolkit developed by the international OpenGATE collaboration. The geometry of this novel beta source, its capsule, and the surrounding water medium were accurately modeled in the simulation input files. The standard Y-90 element beta spectrum from ICRU 72 was used, and the physics processes for beta and photon interactions with matters were all included. The dose distribution of this Y-90 disc source was measured in a separate study using Gafchromic EBT-3 films and the results were reported elsewhere. To match the setup of the experiment, a Gafchromic EBT-3 film was also included in the simulation geometry. The simulated dose profiles were exported from the 3D dose distribution results and compared with the measured dose profiles. Transverse dose profiles at different distances from the seed surface were also obtained to study the lateral coverage of the source. The measured percent depth dose (PDD) curves along the central axis perpendicular to the surface of the Y-90 disc were constructed from the experimental and simulated data, and normalized to the reference point at 1 mm from the source capsule. Both PDD curves agreed well up to 4 mm from the source surface (maximum difference ± 10%) but deviated from each other beyond 4 mm. The deviation might be caused by the increased measurement uncertainty in the low-dose region. The dose rate at the reference point calculated from the Monte Carlo simulation was 1.09 cGy/mCi-s and agreed very well with the measured dose rate of 1.05 cGy/mCi-s. If the 80% isodose line is selected as the lateral coverage, the lateral dose coverage is maximal (∼4.5 mm) at the plane next to the source surface, and gradually decreases with the increasing distance, approaching 3.5 mm when the plane is 5 mm from the 6-mm diameter source surface. Monte Carlo simulations were successfully performed to confirm the measured PDD curve of the novel Y-90 disc source. This simulation work laid a solid foundation for characterizing the full dosimetry parameters of this source for episcleral brachytherapy applications.

Identifiants

pubmed: 37708092
doi: 10.1002/acm2.14140
pmc: PMC10691622
doi:

Substances chimiques

Yttrium-90 1K8M7UR6O1
Yttrium Radioisotopes 0
Water 059QF0KO0R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14140

Informations de copyright

© 2023 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.

Références

Phys Med. 2020 Apr;72:52-59
pubmed: 32200298
Med Phys. 2004 Mar;31(3):633-74
pubmed: 15070264
Arch Ophthalmol. 2006 Dec;124(12):1684-93
pubmed: 17159027
Radiat Oncol. 2020 Jul 29;15(1):183
pubmed: 32727533
Arch Ophthalmol. 1991 Nov;109(11):1610-3
pubmed: 1755746
Ocul Oncol Pathol. 2018 Apr;4(3):145-151
pubmed: 29765944
Brachytherapy. 2023 May-Jun;22(3):416-427
pubmed: 36948988
J Contemp Brachytherapy. 2016 Feb;8(1):66-73
pubmed: 26985199
J Appl Clin Med Phys. 2022 May;23(5):e13571
pubmed: 35226398
Ophthalmology. 2015 Feb;122(2):414-28
pubmed: 25439609
Med Phys. 2020 Jun;47(5):e92-e124
pubmed: 31883269
J Appl Clin Med Phys. 2023 Dec;24(12):e14140
pubmed: 37708092

Auteurs

Xiangyun Chang (X)

MS in Medical Physics Program, Department of Physics and Astronomy, Hofstra University, Hempstead, New York, USA.
Radiation Medicine, Northwell Health, Lake Success, New York, USA.

Lyu Huang (L)

Radiation Medicine, Northwell Health, Lake Success, New York, USA.

Jian Liu (J)

Radiation Oncology, Rhode Island Hospital, Providence, Rhode Island, USA.

Yijian Cao (Y)

MS in Medical Physics Program, Department of Physics and Astronomy, Hofstra University, Hempstead, New York, USA.
Radiation Medicine, Northwell Health, Lake Success, New York, USA.
Radiation Medicine, Zucker School of Medicine at Hofstra/Northwell, Lake Success, New York, USA.

Jenghwa Chang (J)

MS in Medical Physics Program, Department of Physics and Astronomy, Hofstra University, Hempstead, New York, USA.
Radiation Medicine, Northwell Health, Lake Success, New York, USA.
Radiation Medicine, Zucker School of Medicine at Hofstra/Northwell, Lake Success, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH